← back to search

John Busby

University of Bristol · GB
Area of research
Physiology · Sociology and Political Science
Research interest
Research interests include Medicine, Asthma, Internal medicine, Cohort, Intensive care medicine, and MEDLINE.
h-index
citations
1,805
works
24
NIH funding
primary concept
email

Recent publications

Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics
American Journal of Respiratory and Critical Care Medicine 2025cited by 15position: middledoi
International Severe Asthma Registry (ISAR): 2017–2024 Status and Progress Update
Tuberculosis & respiratory diseases 2025cited by 10position: middledoi
Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland
Thorax 2025cited by 9position: middledoi
Investigating the Association Between Biologic Initiation and Medication Adherence in Severe Asthma: An Analysis of Linked Data
The Journal of Allergy and Clinical Immunology In Practice 2025cited by 1position: lastdoi
Association between pre-biologic T2-biomarker combinations and response to biologics in patients with severe asthma
Frontiers in Immunology 2024cited by 26position: middledoi
Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort
Allergy 2024cited by 19position: middledoi
Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry
European Respiratory Journal 2023cited by 137position: middledoi
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry
Annals of Allergy Asthma & Immunology 2023cited by 78position: middledoi
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma
American Journal of Respiratory and Critical Care Medicine 2023cited by 56position: middledoi
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
The Journal of Allergy and Clinical Immunology In Practice 2023cited by 36position: middledoi
Unsupervised home spirometry<i>versus</i>supervised clinic spirometry for respiratory disease: a systematic methodology review and meta-analysis
European Respiratory Review 2023cited by 35position: middledoi
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study
DOAJ (DOAJ: Directory of Open Access Journals) 2022cited by 83position: middle
Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
The Journal of Allergy and Clinical Immunology In Practice 2022cited by 69position: middledoi
Benefits of specialist severe asthma management: demographic and geographic disparities
European Respiratory Journal 2022cited by 32position: lastdoi
Eosinophilic and Noneosinophilic Asthma
CHEST Journal 2021cited by 259position: middledoi
Impact of Socioeconomic Status on Adult Patients with Asthma: A Population-Based Cohort Study from UK Primary Care
Journal of Asthma and Allergy 2021cited by 42position: firstdoi
Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
Thorax 2020cited by 153position: middledoi
Potential Severe Asthma Hidden in UK Primary Care
The Journal of Allergy and Clinical Immunology In Practice 2020cited by 70position: middledoi
International severe asthma registry (ISAR): protocol for a global registry
BMC Medical Research Methodology 2020cited by 54position: middledoi
Characterization of Severe Asthma Worldwide
CHEST Journal 2019cited by 323position: middledoi
Characteristics and treatment regimens across ERS SHARP severe asthma registries
European Respiratory Journal 2019cited by 68position: middledoi
Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma
Clinical Gastroenterology and Hepatology 2018cited by 61position: middledoi
The Diagnosis of Urinary Tract infection in Young children (DUTY): a diagnostic prospective observational study to derive and validate a clinical algorithm for the diagnosis of urinary tract infection in children presenting to primary care with an acute illness
Health Technology Assessment 2016cited by 115position: middledoi
Improving the Diagnosis and Treatment of Urinary Tract Infection in Young Children in Primary Care: Results from the DUTY Prospective Diagnostic Cohort Study
The Annals of Family Medicine 2016cited by 54position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Liam G. Heaney · National University of Singapore7 papers (2020–2025)Paul Pfeffer · Queen Mary University of London3 papers (2020–2022)David J. Jackson · Guy's Hospital3 papers (2020–2023)Andrew Menzies‐Gow · AstraZeneca (United Kingdom)3 papers (2020–2022)J. Mark FitzGerald · Vancouver Coastal Health2 papers (2020–2021)Cherry-Ann Waldron · Cardiff University2 papers (2016–2016)David Price · Virginia Tech2 papers (2020–2021)Alasdair MacGowan · University of Bristol2 papers (2016–2016)Kim Harman · University of Southampton2 papers (2016–2016)Stevo Durbaba · King's College London2 papers (2016–2016)William Hollingworth · London School of Hygiene & Tropical Medicine2 papers (2016–2016)Brendan Delaney · NIHR Imperial Biomedical Research Centre2 papers (2016–2016)Rekha Chaudhuri · Cambridge University Hospitals NHS Foundation Trust2 papers (2022–2023)Alastair D Hay · University of Bristol2 papers (2016–2016)Harriet Downing · University of Bristol2 papers (2016–2016) · 2 papers (2016–2016) · 2 papers (2023–2025)Robin Gore · University of Manchester2 papers (2020–2023)Robin Howe · Houston Methodist2 papers (2016–2016) · 2 papers (2020–2021)